ASEP Medical Holdings Forum: Community User: Rehberger

Es geht wieder aufwärts. Auch wird wieder für ASEP geworben

https://www.boerse-express.com/news/articles/asep-medical-aktie-fokus-sepsis-diagnostik-868410

https://www.ad-hoc-news.de/boerse/news/ueberblick/asep-medical-aktie-strategischer-umbau/68618944

https://asepmedical.com/wp-content/uploads/2026/02/Asep-NR-Heinzl-Appointed-Interim-CEO_022726_FINAL.pdf ..

ASEP MEDICAL HOLDINGS INC. ANNOUNCES LEADERSHIP TRANSITION https://www.stockwatch.com/News/Item/Z-C!ASEP-3787479/C/ASEP Dr. Robert Hancock has stepped down from his roles as chief executive officer and chairman of the board of Asep Medical Holdings Inc. to focus more directly on advancing the company's scientific initiatives.

https://www.newswire.ca/news-releases/canadian-investment-regulatory-organization-trade-resumption-asep-819172610.html Wiederaufnahme des Handels .. Neuigkeiten bereitgestellt von Kanadische Investmentaufsichtsbehörde (CIRO) – Aussetzungen/Wiederaufnahmen  18. Dezember 2025, 10:46 Uhr ET VANCOUVER, BC, 18. Dezember 2025 /CNW/  Der Handel wird wieder aufgenommen  .. ASEP Medical Holdings Inc. ... CSE-Symbol: ASEP ... Wiederaufnahme (ET): 11:00 Uhr

https://www.ad-hoc-news.de/boerse/news/ueberblick/asep-medical-aktie-handel-wiederaufgenommen/68423294

2025-12-16 14:53 ET - News Release https://www.stockwatch.com/News/Item/Z-C!ASEP-3766169/C/ASEP ASEP MEDICAL HOLDINGS ANNOUNCES REVOCATION OF FAILURE-TO-FILE CEASE TRADE ORDER ASEP Medical Holdings Inc.'s principal regulator, the British Columbia Securities Commission (BCSC), has issued a revocation order lifting the failure-to-file cease trade order (FFCTO) previously imposed on the company. The FFCTO was originally issued on May 6, 2025, as a result of the company's delay in filing its annual audited financial statements for the fiscal year ended Dec. 31, 2024, along with the accompanying management discussion and analysis and related certifications within the prescribed time period under applicable securities regulations. During the period in which the FFCTO was in effect, the company continued to operate its core business activities; however, trading in the company's securities was temporarily restricted. The revocation restores normal trading activity. ASEP Medical remains committed to maintaining strong corporate governance practices and timely financial reporting. With the FFCTO now revoked pursuant to National Policy 11-207, Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions, the company will continue to advance its strategic initiatives, including the further development and commercialization of its sepsis diagnostic (SepsetER) and anti-biofilm peptide technology platforms. The company appreciates the patience and continued support of its shareholders and stakeholders throughout this process. ...

December 11, 2025 Asep Medical Holdings Amends and Refiles its Management’s Discussion & Analysis for its Year Ended December 31, 2024 https://asepmedical.com/wp-content/uploads/2025/12/Asep-NR-Amended-MDA-12112025.pdf Eine gute Übersicht der Projekte, Patente und Partnerschaften im aktuellen SEDAR Filling https://thecse.com/listings/asep-medical-holdings-inc/sedar-filings/

Der für den 03.12 angekündigte Quartalsbericht wurde bereits heute nach Börsenschluss veröffentlicht ASEP Medical Holdings Inc. just filed two new SEDAR documents: Interim financial statements/report https://ceo.ca/content/sedar/ASEP-2025-11-28-interim-financial-statementsreport-english-de9b.pdf Interim MD&A https://ceo.ca/content/sedar/ASEP-2025-11-28-interim-mda-english-a87b.pdf Übersicht aller SEDAR Fillings https://thecse.com/listings/asep-medical-holdings-inc/sedar-filings/

Aus dem aktuellen Monatsbericht von ASEP, CSE-filling November, link: https://thecse.com/listings/asep-medical-holdings-inc/cse-filings/ geht hervor, dass die Wiedereinsetzung in den Handel beantragt wurde Zitat: ..On May 6, 2025, the British Columbia Securities Commission (BCSC), the Issuer’s principal regulator, issued a Failure-to-File Cease Trade Order (FFCTO) against Asep Medical Holdings Inc. for not filing th e audited annual financial statements for the year ended December 31, 2024, the related MD&A, and the CEO/CFO certifications. The Issuer filed these documents on SEDAR+ on October 17, 2025. Because the FFCTO has been in effect for more than 90 days, the Issuer filed an NP 11-207 revocation application with the BCSC on October 28, 2025. No administrative penalty was imposed. As of the date of this form, the FFCTO remains in effect pending the BCSC’s decision.